Page last updated: 2024-10-29

ketanserin and Necrosis

ketanserin has been researched along with Necrosis in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Necrosis: The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pang, CY1
Chiu, C1
Zhong, A1
Xu, N1
Achouche, J1
Teisseire, B1
Laccourreye, O1
Hadjean, E1

Other Studies

2 other studies available for ketanserin and Necrosis

ArticleYear
Pharmacologic intervention of skin vasospasm and ischemic necrosis in pigs.
    Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Dose-Response Relationship, Drug; Ergolines; In Vit

1993
[Ketanserin and random skin flaps. An experimental study in the rat].
    Annales de chirurgie plastique et esthetique, 1994, Volume: 39, Issue:2

    Topics: Animals; Ketanserin; Male; Necrosis; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Res

1994